510(k) K864335— WAKO GPT II - HA

Substantially Equivalent

Wako Chemicals USA, Inc.

Clearance details

Applicant: Wako Chemicals USA, Inc.
Product code: Code CKA
Advisory panel: Clinical Chemistry
Date received: 1986-11-04
Decision date: 1986-12-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Dallas, TX, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.